APA

Berkenblit A., Matulonis U. A., Kroener J. F., Dezube B. J., Lam G. N., Cuasay L. C., Brünner N., Jones T. R., Silverman M. H. & Gold M. A. (20051104). A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. : Gynecologic oncology.

Chicago

Berkenblit Anna, Matulonis Ursula A, Kroener Joan F, Dezube Bruce J, Lam Gil N, Cuasay Luceli C, Brünner Nils, Jones Terence R, Silverman Michael H and Gold Michael A. 20051104. A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. : Gynecologic oncology.

Harvard

Berkenblit A., Matulonis U. A., Kroener J. F., Dezube B. J., Lam G. N., Cuasay L. C., Brünner N., Jones T. R., Silverman M. H. and Gold M. A. (20051104). A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. : Gynecologic oncology.

MLA

Berkenblit Anna, Matulonis Ursula A, Kroener Joan F, Dezube Bruce J, Lam Gil N, Cuasay Luceli C, Brünner Nils, Jones Terence R, Silverman Michael H and Gold Michael A. A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. : Gynecologic oncology. 20051104.